Allens has advised private investment company BGH Capital on its AUD2.37 billion (USD1.6 billion) acquisition of the Asia-Pacific business of South Africa-headquartered Aspen Pharmacare.
The transaction involved the acquisition of Aspen’s APAC subsidiaries, spanning Australia, New Zealand, Hong Kong, Malaysia, Taiwan and the Philippines, together with associated intellectual property assets, excluding China. Funds managed or advised by BGH Capital acquired the APAC assets.
Allens advised on all aspects of the transaction, including due diligence, acquisition structuring, ongoing commercial arrangements, and sale and purchase documentation. The sale was led by the firm’s M&A, technology, media and telecommunications, and intellectual property teams, and included co-ordination of foreign counsel across 12 jurisdictions.
Partners Tom Story and Emin Altiparmak, leader of the private capital sector, led the M&A team, while partners Jessica Mottau and Phil O’Sullivan, leader of the healthcare sector, headed the technology, media and telecommunications team.
Other partners involved in the transaction included Caroline Ryan, Ben O’Hoy, Michael Graves, Emily Johnstone, Simon Dewberry and Robert Walker, representing the intellectual property, banking and finance, real estate and development, environment and planning, employment and safety, and competition practices, respectively.
Additional advice on Foreign Investment Review Board matters was provided by partner Jeremy Low, while Allens’ head of Vietnam, Linh Bui, also advised on the deal.
